Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for ...

Brent Willis, Voyageur’s President, CEO and Director, expressed, “We sincerely appreciate the support our existing investors have placed in us. The warrant exercises will give Voyageur added ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

In a digital drug development world, the ability to simulate or predict behaviour of the manufacturing process in silico - from molecular to plant scale - has multiple benefits, including higher ...

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), announced today that a ...

Thai FDA warns against using unapproved smart devices for blood sugar monitoring due to health risks and lack of scientific ...

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Inability to provide accurate and timely diagnosis is one of the major contributors to the misuse and overuse of ...

FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...